Drug Profile
Research programme: serotonin 2C receptor agonists - Athersys
Alternative Names: 5HT2c serotonin receptor agonists - AthersysLatest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Athersys
- Class Small molecules
- Mechanism of Action Serotonin 2C receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- Available For Licensing Yes - Obesity
Highest Development Phases
- No development reported Obesity
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Obesity in USA (PO)
- 03 Feb 2011 Preclinical development is ongoing in USA
- 31 Dec 2008 This programme is available for licensing (http://www.athersys.com)